Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CULP INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Revenue
310
324
281
256
300
295
235
225
213
203
Cost of revenue
240
259
236
216
250
259
224
197
188
178
Gross profit
69.2
64.6
45.8
40.5
49.8
36.1
10.9
27.9
25.1
25.2
Selling, general and administrative
39.2
37.2
33.2
34.4
37.8
35.4
38
38.6
35.7
34.7
Operating income
30.1
27.5
13.4
-7.57
12.1
0.68
-28.5
-11.3
-18.4
-7.19
Interest expense
0
0.09
0.04
0.11
0.05
0.02
0.01
0.23
0.76
Interest income
0.3
0.53
0.79
0.9
0.24
0.37
0.53
1.17
0.92
1.07
Other non-operating income
-0.68
-1.02
-1.38
-0.9
-2.21
-1.36
-0.44
-0.63
-1.02
-1.41
Pre-tax income
29.7
26.9
12.7
-7.68
10.9
-0.33
-28.4
-10.8
-18.7
-8.29
Income tax
7.34
5.74
6.54
3.35
7.69
2.89
3.13
3.05
0.39
1.93
Net income
22.3
20.9
5.68
-28.7
3.22
-3.21
-31.5
-13.8
-19.1
-10.2
EBITDA
37.2
35.1
21.5
0.26
18.9
7.67
-21.6
-4.79
-12.9
-3.08
EPS, basic
1.81
1.68
0.44
-2.32
0.26
-0.26
-2.57
-1.11
-1.53
-0.81
EPS, diluted
1.78
1.65
0.43
-2.32
0.26
-0.26
-2.57
-1.11
-1.53
-0.81
Shares, basic (weighted)
12.3
12.4
12.5
12.4
12.3
12.2
12.3
12.4
12.5
12.6
Shares, diluted (weighted)
12.5
12.6
12.5
12.4
12.3
12.2
12.3
12.4
12.5
12.6
Balance sheet
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
20.8
21.2
40
69.8
37
14.6
21
10
5.63
8.27
Short-term investments
2.44
2.45
0
0.92
5.5
0
Receivables
24.6
26.3
23.4
25.1
37.7
22.2
24.8
21.1
21.8
20.4
Inventory
51.5
53.5
47.6
47.9
55.9
66.6
45.1
44.8
49.3
47.5
Other current assets
2.89
2.87
2.82
2.12
3.85
2.99
3.07
3.37
2.97
2.65
Total current assets
102
132
123
152
143
107
95.5
80.9
83.5
80.7
Property, plant and equipment
51.7
51.8
46.5
43.1
44
41.7
36.1
33.2
24.8
21
Lease right-of-use assets
3.9
11.7
15.6
8.19
6.2
5.91
2.98
Goodwill
11.5
13.6
13.6
0
0
0
Intangible assets
4.28
3.9
3.38
3
2.63
2.25
1.88
0.96
0.36
Other non-current assets
2.39
0.96
0.64
0.66
2.04
0.6
0.84
0.83
0.59
0.56
Total assets
206
218
221
215
214
178
152
132
123
112
Accounts payable
29.1
27.2
22.7
23
42.5
20.1
29.4
25.6
27.3
25.7
Accrued liabilities
11.9
9.33
8.63
5.69
14.8
7.83
8.53
6.73
5.33
4.1
Deferred revenue
0.81
0.4
0.5
0.54
0.52
1.19
1.5
0.42
0.28
Short-term debt
7.61
Total current liabilities
46.1
40.6
35.2
40.1
61.2
32.6
44
38.1
47
45
Lease liabilities
2.02
6.82
7.06
3.61
2.42
2.54
1.03
Total liabilities
57
54.6
56.3
85.4
85.1
58.1
63.1
55.9
65.7
63.8
Paid-in capital
47.4
48.2
43.7
42.6
43.8
43.1
44.3
45
45.6
46.1
Retained earnings
101
115
116
86.5
84.4
75.7
44.2
30.4
11.3
1.06
Other comprehensive income
-0
-0.09
0.04
-0.01
0.15
0.03
0.02
0.12
0.15
0.32
Shareholders' equity
149
163
160
130
Minority interests
4.31
Total equity
149
163
164
130
129
120
89.1
76.1
57.6
48.1
Total liabilities and equity
206
218
221
215
214
178
152
132
123
112
Shares outstanding
12.4
12.5
12.4
12.3
12.3
12.2
12.3
12.5
12.6
12.7
Cash flow statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
22.3
20.9
5.46
-28.7
3.22
-3.21
-31.5
-13.8
-19.1
-10.2
Depreciation and amortization
7.09
7.67
8.12
7.83
6.85
6.99
6.85
6.52
5.44
4.11
Stock-based compensation
3.36
2.21
0.13
0.61
1.25
1.13
1.15
0.92
0.65
0.63
Deferred income tax
4.67
-2.48
2.14
-1.63
3.76
0.69
-0
0.39
-1.34
-0.14
Change in receivables
-1.56
-0.3
2.34
-1.99
-12.1
15.4
-2.64
3.56
-0.72
1.57
Change in inventory
-5.44
-0.02
3.84
-0.84
-8.11
-12.7
15.4
1.59
-2.06
0.01
Cash from operations
34.1
27.5
13.9
4.97
21.5
-17.4
7.8
-8.22
-17.7
-9.37
Capital expenditures
-11.9
-8.01
-3.26
-4.59
-6.66
-5.7
-2.11
-3.71
-2.95
-0.6
Acquisitions
-4.54
-12.1
-0.89
Purchases of investments
-0.04
-0.05
-0.01
-7.47
-8.17
-4.39
Cash from investing
-43.3
-15.1
15.2
-5.71
-10.7
2.5
-0.75
-2.43
0.6
6.38
Stock issued
0.04
0.11
Share buybacks
-3.32
-1.68
-1.75
Dividends paid
-6.28
-6.84
-4.73
-5.08
-5.29
-5.51
Cash from financing
-7.72
-12
-10.2
30.6
-43.7
-7.42
-0.44
-0.13
12.7
5.48
Exchange rate effect
-0.06
0.09
-0.09
-0.12
0.13
-0.09
-0.2
-0.17
-0
0.15
Net change in cash
-17
0.43
18.8
29.8
-32.8
-22.5
6.41
-11
-4.38
2.64
Free cash flow
22.2
19.5
10.6
0.39
14.8
-23.1
5.7
-11.9
-20.6
-9.97
Interest paid
0.11
0.18
0.05
0.12
0.06
Income taxes paid
5.5
4
6.69
5
3
3.1
2.32
3.28
2.3
3.56
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to August 2, 2026; growth uses fiscal years. Valuation uses the share price of $3.56 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
16.1%
Gross profit / revenue.
Operating margin
-1.0%
Operating income / revenue.
EBITDA margin
0.9%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-1.2%
Pre-tax income / revenue.
Net margin
-1.9%
Net income / revenue.
FCF margin
-0.6%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-0.3%
Cash from operations / revenue.
Return on assets (ROA)
-3.7%
Net income / average total assets.
SG&A / revenue
16.6%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.4%
Capital expenditures / revenue.
D&A / revenue
1.9%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-4.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-4.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-7.5%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
0.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
32.2%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-12.8%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-9.2%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-9.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-12.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
0.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.81x
Current assets / current liabilities.
Quick ratio
0.24x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.24x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
50.0%
Total liabilities / total assets.
Interest coverage
-2.92x
Operating income / interest expense.
Working capital
$35.3M
Current assets - current liabilities.
Goodwill and intangibles / assets
0.3%
(Goodwill + intangible assets) / total assets.
Efficiency
Metric
Value
How it is calculated
Asset turnover
1.91x
Revenue / average total assets.
Fixed asset turnover
10.2x
Revenue / average property, plant and equipment.
Inventory turnover
4.11x
Cost of revenue / average inventory.
Days inventory
89 days
365 x average inventory / cost of revenue.
Days payables
47 days
365 x average accounts payable / cost of revenue.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.31
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Market cap + total debt - cash - short-term investments.
P/S
0.22x
Market cap / revenue.
EV/Sales
0.17x
Enterprise value / revenue.
EV/EBITDA
19.8x
Enterprise value / EBITDA, when both are positive.
FCF yield
-2.9%
Free cash flow / market cap.
Earnings yield
-8.8%
Net income / market cap (the inverse of P/E).
What was CULP INC's revenue in fiscal 2026?
CULP INC reported revenue of $203.5M for fiscal 2026, 4.6% lower than the year before.
Was CULP INC profitable in fiscal 2026?
No. It reported a net loss of $10.2M.
How much free cash flow did CULP INC generate in fiscal 2026?
Cash from operations of $9.4M minus capital expenditures of $596.0K left free cash flow of -$10.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.